TSPO and neoplasm: The implantation of these human GSCs produced patient-derived xenografts (PDX) with a high expression of TSPO in the tumor area (Figure 2A) for the classical human GBM (GBM2), as well as for the proneural human GBM (GBM14 and NCH644).